medigraphic.com
ENGLISH

Investigación en Discapacidad

ISSN 2992-779X (Digital)
ISSN 2007-6452 (Impreso)
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2025, Número 3

<< Anterior

Investigación en Discapacidad 2025; 11 (3)


Los beneficios de tratar la discapacidad visual relacionada con catarata

Mundo-Fernández EE, Fuentes-Cataño MC, Fabila-Maya MM, Jiménez-Rosas DF, Messina-Baas OM, Quintanar-Haro OD, Urrutia-Breton IP, Zapata-Tarrés, MM, Lima-Gómez V
Texto completo Cómo citar este artículo 10.35366/123225

DOI

DOI: 10.35366/123225
URL: https://dx.doi.org/10.35366/123225
Artículos similares

Idioma: Español
Referencias bibliográficas: 45
Paginas: 122-130
Archivo PDF: 781.89 Kb.


PALABRAS CLAVE

catarata, cirugía de catarata, discapacidad, facoemulsificación, rehabilitación.

RESUMEN

El objetivo principal de la cirugía de catarata es mejorar la visión, aunque tiene otros efectos sobre la salud en general como aumentar la capacidad de desplazamiento y facilitar la relación interpersonal del paciente. La catarata en adultos mayores puede coexistir con otras causas de discapacidad; su abordaje puede verse limitado debido a la restricción visual. La cirugía de catarata puede facilitar atender otras discapacidades, lo que amplifica su beneficio, aunque la agudeza visual se limite por comorbilidades. En esta revisión narrativa se aborda la discapacidad visual en pacientes con dos enfermedades extraoculares y cuatro oculares. Se destaca el beneficio que puede obtenerse al reducirla mediante la cirugía de catarata.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. McCormick I, Butcher R, Evans JR, Mactaggart IZ,Limburg H, Jolley E et al. Effective cataract surgicalcoverage in adults aged 50 years and older: estimatesfrom population-based surveys in 55 countries. LancetGlob Health. 2022; 10 (12): e1744-e1753.

  2. Vision Loss Expert Group of the Global Burden ofDisease Study; GBD 2019 Blindness and VisionImpairment Collaborators. Global estimates on thenumber of people blind or visually impaired by cataract:a meta-analysis from 2000 to 2020. Eye (Lond). 2024; 38 (11): 2156-2172.

  3. Blachnio K, Dusinska A, Szymonik J, Juzwiszyn J,Bestecka M, Chabowski M. Quality of life after cataractsurgery. J Clin Med. 2024; 13 (17): 5209.

  4. Assi L, Chamseddine F, Ibrahim P, Sabbagh H,Rosman L, Congdon N et al. A global assessment ofeye health and quality of life. A systematic review ofsystematics reviews. JAMA Ophthalmol. 2021; 139:526-541.

  5. Jansone-Langina Z, Solomatin A, Solomatins M,Krumina G. Quality of life assessment for nuclear,cortical, posterior subcapsular patients before and aftercataract surgery. J Optom. 2023; 17 (2): 100489.

  6. Hecht I, Kanclerz P, Tuuminen R. Secondary outcomesof lens and cataract surgery: More than just “bestcorrectedvisual acuity”. Prog Retin Eye Res. 2023; 95:101150.

  7. Afflitto GG, Aiello F, Surico PL, Malek DA, Mori T,Swaminathan SS et al. Cataract and risk of fracture: asystematic review, meta-analysis, and Bayesian networkmeta-analysis, Ophthalmology. 2025; 132: 921-934.

  8. Boyd M, Kvishinadze G, Kho A, Wilson G, Wilson N.Cataract surgery for falls prevention and improvingvision: modelling the health gain, health system costand cost-effectiveness in high-income country. Inj Prev.2020; 26: 302-309.

  9. Baig A, Foss A, Sahota O, Sehat K, Ash I. Visionscreening in older adults admitted with a fragility hipfracture: A healthcare quality improvement report. Br IrOrthopt J. 2023; 19: 96-107.

  10. Al-Namaeh M. Common causes of visual impairmentin the elderly. Med Hypothesis Discov Eye InnovOphthalmol. 2022; 10: 191-200.

  11. Zhang JH, Ramke J, Lee CN, Gordon I, Safi S, LinghamG et al. A systematic review of clinical practice guidelinesfor cataract: evidence to support the development of theWHO package of eye care interventions. Vision (Basel).2022; 6 (2): 36.

  12. Livingston G, Huntley J, Sommerlad A, Ames D, BallardC, Banerjee S et al. Dementia prevention, intervention,and care: 2020 report of the Lancet Commission. Lancet.2020; 396 (10248): 413-446.

  13. Li M, Hamedani AG. Association of visual impairmentwith neuropsychiatric symptoms of dementia. JNeuroophthalmol. 2025; 45: 131-136.

  14. Lee CS, Gibbons LE, Lee AY, Yanagihara RT, BlazesMS et al. Association between cataract extraction anddevelopment of dementia. JAMA Intern Med. 2022; 182:134-141.

  15. Klauke S, Sondocie C, Fine I. The impact of low visionon social function: the potential importance of lost visualsocial cues. J Optom. 2022; 16: 3-11.

  16. Joo H, Diaz-Ramirez LG, Chen CL, Sun CQ, Smith AK,Boscardin WJ et al. Cognitive trajectory before and aftercataract surgery: A population-based approach. J AmGeriatr Soc. 2025; 73: 1073-1081.

  17. Chen PW, Liu PPS, Lin SM, Wang JH, Huang HK, LohCH. Cataract and the increased risk of depression ingeneral population: A 16-year nationwide populationbasedlongitudinal study. Sci Rep. 2020; 10: 13421.

  18. Pershing S, Henderson VW, Goldstein MK, Lu Y,Bundorf MK, Rahman M et al. Cataract surgerycomplexity and surgical complication rates amongMedicare beneficiaries with and without dementia. AmJ Ophthalmol. 2021; 221: 27-38.

  19. Anggarini DW, Handayaningrum VN, Hening BB.Association between cataract surgery and age-relatedmacular degeneration: a systematic review. JARMHS.

  20. 2023; 9 (3): 63-67.20. Mehta H. Management of cataract in patients with agerelatedmacular degeneration. J Clin Med. 2021; 10:2538.

  21. Tang HY, Rosen M, Granstam E. Cataract surgery inneovascular AMD: impact on visual acuity and diseaseactivity. BMC Opthalmol. 2023; 23: 276.

  22. Hossl L, Vaghefi SA, Riemer T, Kabiri P, Bonaventura T,Rübsam A et al. Insights into cataract surgery outcomesin age-related macular degeneration. Perspectivesacross severity grades under clinical routine conditions.Ophthalmol Retina. 2025; 9: 527-536.

  23. Karesvuo P, Elbaz U, Achiron A, Hecht I, KaarnirantaK, Tuuminen R. Effect of cataract surgery on wet agerelatedmacular degeneration activity. Acta Ophthalmol.2022; 100: e262-e269.

  24. Klein J, Pierscionek BK, Lauritzen J, Derntl K,Grzybowski A, Zlatkova MB. The effect of cataracton early stage glaucoma detection using spatial andtemporal contrast sensitivity tests. PLoS One. 2015; 10:e0128681.

  25. Turalba A, Payal AR, Gonzalez-Gonzalez LA, Cakiner-Egilmez T, Chomsky AS, Vollman DE et al. Cataractsurgery outcomes in glaucomatous eyes: results fromthe Veterans affairs ophthalmic surgery outcomes dataproject. Am J Ophthalmol. 2015; 160: 693-701.

  26. Skalicky SE, Martin KR, Fenwick E, Crowston JG,Goldberg I, McCluskey P. Cataract and quality of life inpatients with glaucoma. Clin Exp Ophthalmol. 2015; 43:335-341.

  27. Xu X, Sun Q, Ma YY, Zou HD. Vision-related quality oflife outcomes of cataract surgery in advanced glaucomapatients. J Glaucoma. 2016; 25: e5-11.

  28. Rao HL, Jonnadula GB, Addepalli UK, Senthil S,Garudadri CS. Effect of cataract extraction on visual fieldindex in glaucoma. J Glaucoma. 2013; 22: 164-168.

  29. Chung HJ, Choi JH, Lee YC, Kim SY. Effect of cataractopacity type and glaucoma severity on visual field index.Optom Vis Sci. 2016; 93: 575-578.

  30. Ivanescu A, Popescu S, Gaita L, Albai O, Braha A, TimarR. Risk factors for cataracts in patients with diabetesmellitus. J Clin Med. 2024; 13: 7005.

  31. Das T, Behera UC, Bhattacharjee H, Gilbert C, MurthyGVS, Rajalakshmi R et al. Spectrum of eye disordersin diabetes (SPEED) in India: Eye care facility basedstudy. Report # 1. Eye disorders in people with type 2diabetes mellitus. Indian J Ophthalmol. 2020; 68 (Suppl1): S16-S20.

  32. Wen L, Wang Y, Lin Z, Wang FH, Ding XX, Li D et al.The prevalence and causes of visual impairment in type2 diabetes mellitus in northeast China. J Ophthalmol.2020; 2020: 5969816.

  33. Pérez-Peralta L, Rivera-De la Parra D, Graue-Hernández E, Hernández-Jiménez S, Almeda-Valdés P,Velázquez-Jurado H et al. Visual impairment associatedwith diabetic retinopathy and macular edema: a hospitalbasedstudy. Gac Med Mex. 2023; 159: 203-209.

  34. López-Star EM, Allison-Eckert K, Limburg H, Brea-Rodríguez I, Lansingh VC. Evaluación rápida de laceguera evitable, incluida la retinopatía diabética, enQuerétaro, México. Rev Mex Oftalmol. 2018; 92: 84-93.

  35. Madueña-Angulo SE, Beltran-Ontiveros SA, Leal-Leon E, Contreras-Gutierrez JA, Lizárraga-VerdugoE, Gutiérrez-Arzapalo PY et al. National sex- and agespecificburden of blindness and vision impairment bycause in Mexico in 2019: a secondary analysis of theGlobal Burden of Disease Study 2019. Lancet RegHealth Am. 2023; 24: 100552.

  36. Monestam EI. Long-term results of cataract surgeryin type 2 diabetics, a 20 year prospective longitudinalstudy. Acta Ophthalmol. 2024; 102: 58-67.

  37. Han MM, Song W, Conti T, Conti FF, Greenlee T, HomG et al. Visual acuity outcomes after cataract extractionwith intraocular lens implantation in eyes with diabeticretinopathy. Ophthalmol Retina. 2020; 4: 351-360.

  38. Lee D, Agron E, Keenan T, Lovato J, Ambrosius W,Chew et al. Visual acuity outcomes after cataract surgeryin type 2 diabetes: the Action to Control CardiovascularRisk in Diabetes (ACCORD) Study. Br J Ophthalmol.2022; 105: 1496-502.

  39. Liu L, Herrinton LJ, Alexeef S, Karter AJ, Amsden LB,Carolan J et al. Visual outcomes after cataract surgeryin patients with type 2 diabetes. J Cataract Refract Surg.2019; 45: 404-413.

  40. Silva LM, Muccioli C, Oliveira FD, Arantes TE, GonzagaLR, Nakanami CR. Visual impairment from uveitis in areference hospital of Southeast Brazil: a retrospectivereview over a twenty years period. Arq Bras Oftalmol.2013; 76: 366-369.

  41. Levin MH, Pistilli M, Daniel E, Gangaputra SS,Nussenblatt RB, Rosenbaum JT et al. Systemicimmunosuppressive therapy for eye diseases cohortstudy. Incidence of visual improvement in uveitis caseswith visual impairment caused by macular edema.Ophthalmology. 2014; 121: 588-595.

  42. Rohl A, Patnaik JL, Lynch AM, Palestine AG. Timingof quiescence and uveitis recurrences after cataractsurgery in patients with a history of uveitis. OphthalmolTher. 2021; 10: 619-628.

  43. Shekhar M, Chaudhary S, Pai A, Rajesh V, BalakrishnanL, Nagu K et al. Visual outcomes and risk factors ofuveitis cataract eyes after phacoemulsification andmanual small-incision cataract surgery. J CataractRefract Surg. 2024; 50: 257-263.

  44. Palson S, Pivodic A, Gronlund M, Lunstrom M, Viberg A,Behndig A et al. Cataract surgery in patients with uveitis:Data from the Swedish National Cataract Register. ActaOphthalmologica. 2023; 101: 376-383.

  45. Jeviknar K, Pockar S, Umek L, Rothova A, ValentincicNV. Prognostic factors of cataract surgery in patientswith uveitis. Int Ophthalmol. 2023; 43: 4605-4612.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Investigación en Discapacidad. 2025;11

ARTíCULOS SIMILARES

CARGANDO ...